These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34638632)

  • 1. Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease.
    Gil L; Niño SA; Guerrero C; Jiménez-Capdeville ME
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formaldehyde, Epigenetics, and Alzheimer's Disease.
    Wang F; Chen D; Wu P; Klein C; Jin C
    Chem Res Toxicol; 2019 May; 32(5):820-830. PubMed ID: 30964647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.
    Yu CC; Jiang T; Yang AF; Du YJ; Wu M; Kong LH
    Neural Plast; 2019; 2019():6856327. PubMed ID: 31093272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and Alzheimer's disease connection: Nuclear Tau and lamin A.
    Gil L; Niño SA; Capdeville G; Jiménez-Capdeville ME
    Neurosci Lett; 2021 Apr; 749():135741. PubMed ID: 33610669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains.
    Klein HU; McCabe C; Gjoneska E; Sullivan SE; Kaskow BJ; Tang A; Smith RV; Xu J; Pfenning AR; Bernstein BE; Meissner A; Schneider JA; Mostafavi S; Tsai LH; Young-Pearse TL; Bennett DA; De Jager PL
    Nat Neurosci; 2019 Jan; 22(1):37-46. PubMed ID: 30559478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
    Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
    Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Nuclear Hallmarks in Dentate Granule Cells of Alzheimer's Patients: A Biphasic Regulation of Neurogenesis.
    Gil L; Chi-Ahumada E; Niño SA; Capdeville G; Méndez-Torres AM; Guerrero C; Rebolledo AB; Olazabal IM; Jiménez-Capdeville ME
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Tau and Its Potential Role in Alzheimer's Disease.
    Bukar Maina M; Al-Hilaly YK; Serpell LC
    Biomolecules; 2016 Jan; 6(1):9. PubMed ID: 26751496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation regulates tau's phase separation behavior and interactions with chromatin.
    Abasi LS; Elathram N; Movva M; Deep A; Corbett KD; Debelouchina GT
    Commun Biol; 2024 Mar; 7(1):251. PubMed ID: 38429335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.
    Gil L; Niño SA; Chi-Ahumada E; Rodríguez-Leyva I; Guerrero C; Rebolledo AB; Arias JA; Jiménez-Capdeville ME
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease.
    Mi K; Johnson GV
    Curr Alzheimer Res; 2006 Dec; 3(5):449-63. PubMed ID: 17168644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear tau, a key player in neuronal DNA protection.
    Sultan A; Nesslany F; Violet M; Bégard S; Loyens A; Talahari S; Mansuroglu Z; Marzin D; Sergeant N; Humez S; Colin M; Bonnefoy E; Buée L; Galas MC
    J Biol Chem; 2011 Feb; 286(6):4566-75. PubMed ID: 21131359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
    De Plano LM; Saitta A; Oddo S; Caccamo A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.
    Ferreira A; Bigio EH
    Mol Med; 2011; 17(7-8):676-85. PubMed ID: 21442128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging dependent effect of nuclear tau.
    Gil L; Federico C; Pinedo F; Bruno F; Rebolledo AB; Montoya JJ; Olazabal IM; Ferrer I; Saccone S
    Brain Res; 2017 Dec; 1677():129-137. PubMed ID: 28974363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
    Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
    Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.